Yıl: 2022 Cilt: 18 Sayı: 2 Sayfa Aralığı: 148 - 154 Metin Dili: İngilizce DOI: 10.4274/ejbh.galenos.2022.2021-9-2 İndeks Tarihi: 21-06-2022

The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements

Öz:
Objective: The survival of patients with breast cancer has prolonged due to early diagnosis and modern methods of treatment and lymphedema has become the most important morbidity secondary to the treatment of the disease. Early detection and timely intervention have potential to reduce advanced breast cancer-related lymphedema. The aims of this study were to comparatively determine the frequency of subclinical/clinical lymphedema by using prospective monitoring with bioimpedance spectroscopy (BIS) and circumferential measurements in a group of patients who underwent breast cancer surgery. Materials and Methods: Patients having breast cancer surgery were recruited between October 2018 and December 2019. Demographical and surgical properties were recorded. Extremity volumes by circumferential and BIS measurements were performed after surgery (baseline) and monitorizations were carried out at third and sixth months, in order to determine the frequency of subclinical/clinical lymphedema. L-Dex value of >6.5 was recently taken attention as subclinical lymphedema and values >7 were considered as clinical lymphedema. The presence of subclinical and clinic lymphedema was assessed by inter-limb volume difference (>5% and >10 respectively) based on the serial circumferential measurements in both affected and non-affected extremities. The functional status and quality of Life (QoL) were determined by quick-DASH and LYMQOL-Arm questionnaires respectively. The relationship between volume measurements, functional status and QoL scores were determined. Results: Eighty-two female patients with a mean age of 49.6 years were included to the study. 30 (36.5%) and 21 (25.6%) of patients were determined as having subclinical/clinical lymphedema by BIS, while 18 (21.9%) and 19 (23.1%) of patients had subclinical/clinical lymphedema by circumferentialmeasurements at third-and-sixth months respectively. The functional and QoL scores were not correlated with circumferential volume measurements and BIS scores. There was a moderate-high correlation with BIS and circumferential measurements. Conclusion: In conclusion 36.5% and 25.6% of our study group had subclinical and clinical lymphedema by BIS respectively during the 6 months surveillance period. Periodic monitoring of women with BIS allows early detection for lymphedema in more patients than in circumferential volume measurements, which may have implications for timely and necessary management.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Torgbenu E, Luckett T, Buhagiar MA, Chang S, Phillips JL. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer 2020; 209: 604. (PMID: 32600278) [Crossref ]
  • 2. Özmen V, Özmen T, Doğru V. Breast Cancer in Turkey; An Analysis of 20.000 Patients with Breast Cancer. Eur J Breast Health 2019; 15: 141- 146. (PMID: 31312788) [Crossref ]
  • 3. McLaughlin SA, Staley AC, Vicini F, Thiruchelvam P, Hutchison NA, Mendez J, et al. Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions. Ann Surg Oncol 2017; 24: 2818-2826. (PMID: 28766232) [Crossref ]
  • 4. Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med 2018; 379: 1937-1944. (PMID: 30428297) [Crossref ]
  • 5. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004; 187: 69-72. (PMID: 14706589) [Crossref ]
  • 6. Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L. Diagnosis of upper quadrant lymphedema secondary to cancer: Clinical practice guideline from the oncology section of the American Therapy Association. Phys Ther 2017; 97: 729-745. (PMID: 28838217) [Crossref ]
  • 7. Dylke ES, Schembri GP, Bailey DL, Bailey E, Ward LC, Refshauge K, et al. Diagnosis of upper limb lymphedema development of an evidencebased approach. Acta Oncol 2016; 55: 1477-1483. (PMID: 27333213) [Crossref ]
  • 8. Bulley C, Gaal S, Coutts F, Blyth C, Jack W, Chetty U, et al. Comparison of breast-cancer-related lymphedema (upper limb swelling) prevalence estimated using objective and subjective criteria and relationship with quality of life. Biomed Res Int 2013; 2013: 807569. (PMID: 23853774) [Crossref ]
  • 9. Bundred NJ, Stockton C, Keeley V, Riches K, Ashcroft L, Evans A, et al. Compasiron of multi-frequency bioimpedance with perometry for the early detection and intervention of lympheoedema after axillary node clearance for breast cancer. Breast Cancer Res Treat 2015; 151: 121-129. (PMID: 25850535) [Crossref ]
  • 10. Heller DR, Killelea BK, Sanft T. Prevention is key: Importance of early recognition and referral in combating breast cancer-related lymphedema. J Oncol Pract 2019; 15: 263-265. (PMID: 31075214) [Crossref ]
  • 11. Kaufman DI, Shah C, Vicini FA, Rizzi M. Utiliation of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema. Breast Cancer Res Treat 2017; 166: 809-815. (PMID: 28831632) [Crossref ]
  • 12. Coroneos CJ, Wong FC, DeSynder SM, Shaitelman SF, Schaverian MV. Correlation of L-Dex Bioimpedance spectroscopy with limb volume and lymphatic function in lymphedema. Lymphat Res Biol 2019; 17: 301- 307. (PMID: 30388062) [Crossref ]
  • 13. Seward C, Skolny M, Brunelle C, Asdourian M, Salama L, Taghian AG. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema. J Surg Oncol 2016; 114: 537-542. (PMID: 27393376) [Crossref ]
  • 14. Soran A, Menekşe E, Girgis M, DeGore L, Johnson R. Breast cancerrelated lymphedema after axillary lymph node dissection: does early posteoperative prediction model work? Support Care Cancer 2016; 24: 1413-1419. (PMID: 26349574) [Crossref ]
  • 15. Vicini F, Shah C, Whitworth P, Walker M, Shi J. Correlation of bioimpedance spectroscopy with risk factors for the development of breast cancer-related lymphedema. Lymphat Res Biol 2018; 16: 533-537. (PMID: 30133336) [Crossref ]
  • 16. Whitworth PW, Cooper A. Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpednace spectroscopy. Breast J 2018; 24: 62-65. (PMID: 29063664) [Crossref ]
  • 17. Gebruers N, Verbelen H, De Vrieze T, Vos L, Devoogdt N, Fias L, et al. Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: A best practice guideline. Eur J Obstet Gynecol Reprod Biol 2017; 216: 245- 253. (PMID: 28811052) [Crossref ]
  • 18. Keeley V. The Early Detection of Breast Cancer Treatment-Related Lymphedema of the Arm. Lymphat Res Biol 2021; 19: 51-55. (PMID: 33270493) [Crossref ]
  • 19. Ridner SH, Dietrich MS, Spotanski K, Doersam JK, Cowher MS, Taback B, et al. A prospective study of L-Dex values in breast cancer patients pretreatment and through 12 months postoperatively. Lymphat Res Biol 2018; 16: 435-441. (PMID: 30130147) [Crossref ]
  • 20. Erdogan Iyigun Z, Selamoglu D, Alco G, Pilancı KN, Ordu C, Agacayak F, et al. Bioelectrical impedance for detecting and monitoring lymphedema in patients with breast cancer. Preliminary results of the flörence nightingale breast study group. Lymphat Res Biol 2015; 13: 40- 45. (PMID: 25526543) [Crossref ]
  • 21. Purnell JQ. Definitions, Classification, and Epidemiology of Obesity. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. (PMID: 25905390) [Crossref ]
  • 22. Cserni G, Chmielik E, Cserni B, Tot T. The new TNM-based staging of breast cancer. Virchows Arch 2018; 472: 697-703. (PMID: 29380126) [Crossref ]
  • 23. De Vrieze T, Gebruers N, Tjalma WA, Nevelsteen I, Thomis S, De Groef A, et al. What is the best method to determine excessive arm volume in patients with breast cancer-related lyphoedema in clinical practice? Reliability, time efficiency and clinical feasibility of five different methods. Clin Rehabil 2019; 33: 1221-1232. (PMID: 30880473) [Crossref ]
  • 24. Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology 2020; 53: 3-19. (PMID: 32521126) [Crossref ]
  • 25. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper extremity volume estimation: Comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther 2003; 83: 134-145. (PMID: 12564949) [Crossref ]
  • 26. Laidley A, Anglin B. The Impact of L-Dex(®) Measurements in Assessing Breast Cancer-Related Lymphedema as Part of Routine Clinical Practice. Front Oncol 2016; 6: 192. (PMID: 27656420) [Crossref ]
  • 27. Vicini F, Shah C, Lyden M, Whitworth P. Bioelectrical impedance for detecting and monitoring patients for the development of upper limb lymphedema in the clinic. Clin Breast Cancer 2012; 12: 133-137. (PMID: 22444720) [Crossref ]
  • 28. Shah C, Vicini FA, Arthur D. Bioimpedance spectroscopy for breast cancer related lymphedema assessment: clinical practice guidelines. Breast J 2016; 22: 645-650. (PMID: 27487985) [Crossref ]
  • 29. Ward LC, Dylke E, Czerniec S, İsenring E, Kilbreath SL. Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 2011; 9: 47-51. (PMID: 21417767) [Crossref ]
  • 30. Greene AR, Goss JA. Diagnosis and staging of lymphedema. Semin Plast Surg 2018; 32: 12-16. (PMID: 29636648) [Crossref ]
  • 31. Koldas Dogan S, Ay S, Evcik D, Baser O. Adaptation of Turkish version of the questionnaire of the Quick disability of the arm, shoulder and hand (Quick DASH) in patients with carpal tunnel syndrome. Clin Rheumatol 2011; 30: 185-191. (PMID: 20411289) [Crossref ]
  • 32. Borman P, Yaman A, Denizli M, Karahan S, Özdemir O. The reliability and validity of Lymphedema Quality Of Life Questionnaire-Arm in Turkish patients with upper limb lymphedema related with breast cancer. Turk J Phys Med Rehabil 2018; 64: 205-212. (PMCID: PMC6657787) [Crossref ]
  • 33. Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R. A quality of life measure for limb lymphoedema (LYMQOL). Journal of Lymphoedema 2010; 5: 26-37. [Crossref ]
  • 34. Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol 2014; 12: 289-294. (PMID: 25495384) [Crossref ]
  • 35. O’Toole J, Jammallo LS, Skolny MN, Miller CL, Elliott K, Specht MC, et al. Lymphedema following treatment for breast cancer: A new approach to an old problem. Crit Rev Oncol Hematol 2013; 88: 437- 446. (PMID:23777977) [Crossref ]
  • 36. Lee TS, Morris CM, Czerniec SA, Mangion AJ. Does Lymphedema Severity Affect Quality of Life? Simple Question. Challenging Answers. Lymphat Res Biol 2018; 16: 85-91. (PMID: 28453410) [Crossref ]
  • 37. Lanza M, Bergmann A, Ferreira MG, de Aguiar SS, Dias Rde A, Abrahão Kde S, et al. Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer. Int J Breast Cancer 2015; 2015: 586827. (PMID: 26843988) [Crossref ]
APA BORMAN P, Yaman A, Doğan L, Arıkan Dönmez A, BALCAN A, Koyuncu E, AKSOY S, Ozaslan C, AKIN IŞIK R, ÜNEŞ K (2022). The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. , 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
Chicago BORMAN PINAR,Yaman Ayşegül,Doğan Lütfi,Arıkan Dönmez Ayşe,BALCAN Ayşegül,Koyuncu Esra Gizem,AKSOY SERCAN,Ozaslan Cihangir,AKIN IŞIK Rabiye,ÜNEŞ KANİYE The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. (2022): 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
MLA BORMAN PINAR,Yaman Ayşegül,Doğan Lütfi,Arıkan Dönmez Ayşe,BALCAN Ayşegül,Koyuncu Esra Gizem,AKSOY SERCAN,Ozaslan Cihangir,AKIN IŞIK Rabiye,ÜNEŞ KANİYE The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. , 2022, ss.148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
AMA BORMAN P,Yaman A,Doğan L,Arıkan Dönmez A,BALCAN A,Koyuncu E,AKSOY S,Ozaslan C,AKIN IŞIK R,ÜNEŞ K The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. . 2022; 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
Vancouver BORMAN P,Yaman A,Doğan L,Arıkan Dönmez A,BALCAN A,Koyuncu E,AKSOY S,Ozaslan C,AKIN IŞIK R,ÜNEŞ K The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. . 2022; 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
IEEE BORMAN P,Yaman A,Doğan L,Arıkan Dönmez A,BALCAN A,Koyuncu E,AKSOY S,Ozaslan C,AKIN IŞIK R,ÜNEŞ K "The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements." , ss.148 - 154, 2022. 10.4274/ejbh.galenos.2022.2021-9-2
ISNAD BORMAN, PINAR vd. "The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements". (2022), 148-154. https://doi.org/10.4274/ejbh.galenos.2022.2021-9-2
APA BORMAN P, Yaman A, Doğan L, Arıkan Dönmez A, BALCAN A, Koyuncu E, AKSOY S, Ozaslan C, AKIN IŞIK R, ÜNEŞ K (2022). The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. European Journal of Breast Health, 18(2), 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
Chicago BORMAN PINAR,Yaman Ayşegül,Doğan Lütfi,Arıkan Dönmez Ayşe,BALCAN Ayşegül,Koyuncu Esra Gizem,AKSOY SERCAN,Ozaslan Cihangir,AKIN IŞIK Rabiye,ÜNEŞ KANİYE The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. European Journal of Breast Health 18, no.2 (2022): 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
MLA BORMAN PINAR,Yaman Ayşegül,Doğan Lütfi,Arıkan Dönmez Ayşe,BALCAN Ayşegül,Koyuncu Esra Gizem,AKSOY SERCAN,Ozaslan Cihangir,AKIN IŞIK Rabiye,ÜNEŞ KANİYE The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. European Journal of Breast Health, vol.18, no.2, 2022, ss.148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
AMA BORMAN P,Yaman A,Doğan L,Arıkan Dönmez A,BALCAN A,Koyuncu E,AKSOY S,Ozaslan C,AKIN IŞIK R,ÜNEŞ K The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. European Journal of Breast Health. 2022; 18(2): 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
Vancouver BORMAN P,Yaman A,Doğan L,Arıkan Dönmez A,BALCAN A,Koyuncu E,AKSOY S,Ozaslan C,AKIN IŞIK R,ÜNEŞ K The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements. European Journal of Breast Health. 2022; 18(2): 148 - 154. 10.4274/ejbh.galenos.2022.2021-9-2
IEEE BORMAN P,Yaman A,Doğan L,Arıkan Dönmez A,BALCAN A,Koyuncu E,AKSOY S,Ozaslan C,AKIN IŞIK R,ÜNEŞ K "The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements." European Journal of Breast Health, 18, ss.148 - 154, 2022. 10.4274/ejbh.galenos.2022.2021-9-2
ISNAD BORMAN, PINAR vd. "The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements". European Journal of Breast Health 18/2 (2022), 148-154. https://doi.org/10.4274/ejbh.galenos.2022.2021-9-2